PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors

類似資料

• Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation
  著者:: Mohammad, Ramzi M., 等
  出版事項: (2017)
• Novel p21-activated kinase 4 (PAK4) allosteric modulators overcome drug resistance and stemness in pancreatic ductal adenocarcinoma
  著者:: Aboukameel, Amro, 等
  出版事項: (2016)
• Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance
  著者:: Khan, Husain Yar, 等
  出版事項: (2019)
• Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
  著者:: Azmi, Asfar S., 等
  出版事項: (2017)
• Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition
  著者:: Azmi, Asfar S., 等
  出版事項: (2015)